Genscript Biotech's high P/S ratio is due to its promising revenue outlook. The company's strong performance and bright future are likely to keep supporting the share price unless conditions change.
GenScript's leadership values Dr. Liu's expertise in genome editing, chemistry, and synthetic biology for its potential to offer key insights. His addition to the SAB is anticipated to boost GenScript's platform and hasten transformative breakthroughs for patients.
Dr. June joining GenScript's SAB could provide invaluable insights for their initiatives, especially in cell and gene therapy. His expertise may accelerate the development of novel therapies.
$Hang Seng Index (800000.HK)$plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion. Pharmaceuticals were sold off.$REMEGEN (09995.HK)$once collapsed 27.5% to $22.8; last at $24.9, down 21%. $CLOVER BIO-B (02197.HK)$nosedived 9.6% to $0.47, hitting record low.$VIVA BIOTECH (01873.HK)$...
Despite Genscript Biotech's promising revenue outlook, its P/S ratio isn't higher than industry peers due to potential volatility in revenue forecasts. Investors should note the company's 2 warning signs.
The continuous sell-off of shares by insiders could be concerning for shareholders, as this does not reflect confidence in the company’s outlook. This activity indicates that investors may need to exercise caution when considering investment in Genscript Biotech.
Genscript Biotech, though in debt, retains substantial net cash, suggesting manageable debt. Its remarkable revenue surge last year could point to future profitability, but its presently unprofitability at the EBIT level and recent negative cash outflows suggest more capital might be needed. The overall risk for Genscript Biotech is notable at this point.
$GENSCRIPT BIO (01548.HK)$ The development trend of Kingsley company is thriving, and the strength of the short market is like the vehicle on the wrong side of the lane in the rush, its outcome will be faced with a tragic situation, Monday short market to borrow shares, the results of low by Hong Kong shares to do more money to buy 1.31 million shares.
An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.
GENSCRIPT BIO Stock Forum
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...
There was HKD95.3 million Southbound Trading net outflow from $GENSCRIPT BIO (01548.HK)$ .
For $SH->HK Connect (GangGuTong.HK)$ , $CHINA MOBILE (00941.HK)$ was the most active stock with highest net inflow of HKD205.2 million, while $HUANENG POWER (00902.HK)$ was the m...
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...
The development trend of Kingsley company is thriving, and the strength of the short market is like the vehicle on the wrong side of the lane in the rush, its outcome will be faced with a tragic situation, Monday short market to borrow shares, the results of low by Hong Kong shares to do more money to buy 1.31 million shares.
No comment yet